The Oncology Institute, Inc.
TOI
$0.716
$0.09114.56%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -70.24M | -71.54M | -72.96M | -83.07M | -75.32M |
| Total Depreciation and Amortization | 6.16M | 6.28M | 6.09M | 5.87M | 5.49M |
| Total Amortization of Deferred Charges | 6.28M | 6.26M | 6.24M | 6.21M | 6.19M |
| Total Other Non-Cash Items | 11.41M | 16.05M | 19.48M | 32.32M | 26.53M |
| Change in Net Operating Assets | 11.77M | -803.00K | 4.40M | 2.36M | -9.31M |
| Cash from Operations | -34.62M | -43.75M | -36.75M | -36.32M | -46.42M |
| Capital Expenditure | -2.90M | -4.23M | -3.34M | -4.57M | -5.70M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -156.00K | -156.00K | -4.46M | -4.46M | -4.77M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 62.64M | 61.28M | 71.42M | 71.66M | 28.91M |
| Cash from Investing | 59.59M | 56.90M | 63.63M | 62.64M | 18.44M |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -3.31M | -1.73M | -3.08M | -3.37M | -5.12M |
| Issuance of Common Stock | 188.00K | 201.00K | 199.00K | 126.00K | 455.00K |
| Repurchase of Common Stock | 0.00 | -125.00K | -1.02M | -1.02M | -1.02M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.99M | -3.97M | -2.18M | -2.58M | -230.00K |
| Cash from Financing | -5.11M | -5.62M | -6.08M | -6.85M | -5.91M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.87M | 7.53M | 20.81M | 19.48M | -33.89M |
